Similarly, children and adolescents under chronic risperidone treatment showed a higher weight gain and, concurrently, changes in gut microbiota consisting in an altered ratio of Bacteroidetes: Firmicutes and an upregulation of metabolic pathways linked with weight gain, including alterations in butanoate, propanoate, fatty acid and tryptophan pathways [249]
Provider Clearance Guidelines Ensure no contraindications, assess metabolic status, review cardiovascular risk factors
There is no official modification to fiber recommendations specifically for GLP-1 users in current clinical guidelines from the American Diabetes Association or the American College of Physicians
Potential Research Applications: Sustained growth hormone release studies Muscle growth, recovery, and anti-aging research models Fat metabolism and body composition investigations Long-acting GHRH analog research For laboratory research only